Grants per year
Personal profile
Research Interests
Clinically, I am interested in early detection and early treatment of emerging psychotic disorders to protect cognition and prevent disability. My primary research interest interest is in biological markers of neuropsychiatric conditions, especially anatomical and neurocognitive endophenotypes of severe mental illnesses such as schizophrenia. Recent projects have used structural magnetic resonance imaging to correlate cognitive performance and symptoms with anatomical changes. Ongoing projects include longitudinal studies of subjects at risk for developing schizophrenia and clinical research into strategies for enhancing cognition in schizophrenia.
Certifications and Licenses
Psychiatry |
Training Experience
2008 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Tulane University
… → 2004
Research interests keywords
- AIDS
- Behavioral Medicine
- Computational Neuroscience
- HIV Infection
- Mental Health
- Neuropsychology
- Psychiatry
- Schizophrenia
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants
- 5 Finished
-
Prot# 31-11-283: A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot Compared with 6-month Retrospective Treatment with Oral Antipsychotics in a
Meltzer, H. Y. (PD/PI) & Cronenwett, W. J. (Co-PD/PI)
Covance Inc., Otsuka Pharmaceutical Development & Commericalization, Inc.
3/5/12 → 3/5/17
Project: Research project
-
Prot# CILO522DUS03T: Effects of Iloperidone on Social Cognitive Performance
Csernansky, J. G. (PD/PI), Cronenwett, W. J. (Co-PD/PI) & Smith, M. (Co-PD/PI)
Novartis Pharmaceuticals Corporation
12/15/11 → 6/30/15
Project: Research project
-
Prot# IND 108186: Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients with Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Cronenwett, W. J. (PD/PI)
Research Foundation for Mental Hygiene, Inc., Sunovion Pharmaceuticals Inc.
1/8/11 → 12/31/13
Project: Research project
-
Prot# CAQW051A2202: A Single-Dose, Placebo-Controlled, Stratified, Randomized, Double-Blind, Crossover Study to Determine the Pharmacodynamic Effects of AQW051 Followed by a 4-Week Multiple-Dose, Placebo-Controlled, Stratified, Randomized, Double-Blind,
Cronenwett, W. J. (PD/PI) & Csernansky, J. G. (Co-PD/PI)
Novartis Pharmaceuticals Corporation
3/3/09 → 12/31/11
Project: Research project
-
Neuromorphometry in Schizophrenia by Computer Algorithm
Csernansky, J. G. (PD/PI), Cronenwett, W. J. (Co-Investigator) & Parrish, T. B. (Co-Investigator)
National Institute of Mental Health
7/1/08 → 6/30/12
Project: Research project
-
Thalamic Shape Abnormalities Differentially Relate to Cognitive Performance in Early-Onset and Adult-Onset Schizophrenia
Cobia, D., Rich, C., Smith, M. J., Engel Gonzalez, P., Cronenwett, W., Csernansky, J. G. & Wang, L., Apr 11 2022, In: Frontiers in Psychiatry. 13, 803234.Research output: Contribution to journal › Article › peer-review
Open Access -
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial
Barch, D. M., Marder, S. R., Harms, M. P., Jarskog, L. F., Buchanan, R. W., Cronenwett, W., Chen, L. S., Weiss, M., Maguire, R. P., Pezous, N., Feuerbach, D., Lopez-Lopez, C., Behrje, R. B. & Gomez-Mancilla, B., Nov 3 2016, In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 71, p. 66-75 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects
Smith, M. J., Cobia, D. J., Wang, L., Alpert, K. I., Cronenwett, W. J., Goldman, M. B., Mamah, D., Barch, D. M., Breiter, H. C. & Csernansky, J. G., Mar 2014, In: Schizophrenia bulletin. 40, 2, p. 287-299 13 p.Research output: Contribution to journal › Article › peer-review
Open Access56 Scopus citations -
Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia
Cronenwett, W. J. & Csernansky, J. G., Sep 15 2013, In: Biological psychiatry. 74, 6, p. 396-397 2 p.Research output: Contribution to journal › Comment/debate › peer-review
4 Scopus citations -
Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia
Smith, M. J., Wang, L., Cronenwett, W., Goldman, M. B., Mamah, D., Barch, D. M. & Csernansky, J. G., Sep 2011, In: Schizophrenia Research. 131, 1-3, p. 174-183 10 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations